Azadirachta indica - A multicentric double blind homoeopathic pathogenetic trial

Abstract

Objective : To elicit pathogenetic response of the drug Azadirachta indica in homoeopathic potencies on healthy human volunteers. Methodology : Drug Azadirachta indica was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was conducted at 2 centres. The pathogenetic trial of the drug was carried out in three potencies (6C,.30C and 200C) on 27 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. All the drug samples were coded. In the first phase, volunteers were given 56 doses (04 doss per day for 14 days) of placebo. In the next three phases 56 doses (04 doses per day for 14 days) of the drug in each of the three potencies was given. The symptoms generated during the trial period were noted by the volunteers, cross examined and elaborated by the Proving Masters. The data obtained from both the centres was compiled at proving-cum-data processing cell at CCRH headquarters after decoding. Observation : Symptoms more or less related to every part of the body appeared during the course of administration of the drug in each trial-potency. Conclusion : Pathogenetic responses (new or reconfirmed), elicited during the trial expands the scope of use of Azadirachta indica and it will benefit the research scholars and clinicians. These symptoms will carry moe value when verified clinically.